XML 21 R7.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Shareholders' Deficit - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Treasury Stock
Paid-in Capital
(Deficit)
(Deficit)
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss, Net
Balance as of beginning period (in shares) at Dec. 27, 2017     107,740          
Balance as of beginning period at Dec. 27, 2017 $ (97,360) $ (15,446) $ 1,077 $ (355,626) $ 594,166 $ (334,661) $ (15,446) $ (2,316)
Balance as of beginning of period, treasury stock (in shares) at Dec. 27, 2017       (43,151)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 43,693         43,693    
Other comprehensive loss (1,830)             (1,830)
Share-based compensation on equity classified awards, net 4,325       4,325      
Purchase of treasury stock (in shares)       (3,901)        
Purchase of treasury stock (61,189)     $ (61,189)        
Equity forward contract issuance/settlement (6,763)       (6,763)      
Issuance of common stock for share-based compensation (in shares)     447          
Issuance of common stock for share-based compensation 0   $ 5   (5)      
Exercise of common stock options (in shares)     398          
Exercise of common stock options 1,225   $ 4   1,221      
Balance as of end of period (in shares) at Dec. 26, 2018     108,585          
Balance as of end of period at Dec. 26, 2018 (133,345) $ (394) $ 1,086 $ (416,815) 592,944 (306,414) $ (394) (4,146)
Balance as of end of period, treasury stock (in shares) at Dec. 26, 2018       (47,052)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 117,410         117,410    
Other comprehensive loss (29,814)             (29,814)
Share-based compensation on equity classified awards, net 3,310       3,310      
Purchase of treasury stock (in shares)       (4,879)        
Purchase of treasury stock (96,202)     $ (96,202)        
Equity forward contract issuance/settlement (in shares)       (389)        
Equity forward contract issuance/settlement 0     $ (6,763) 6,763      
Issuance of common stock for share-based compensation (in shares)     468          
Issuance of common stock for share-based compensation 0   $ 5   (5)      
Exercise of common stock options (in shares)     362          
Exercise of common stock options $ 971   $ 3   968      
Balance as of end of period (in shares) at Dec. 25, 2019 109,415   109,415          
Balance as of end of period at Dec. 25, 2019 $ (138,064)   $ 1,094 $ (519,780) 603,980 (189,398)   (33,960)
Balance as of end of period, treasury stock (in shares) at Dec. 25, 2019 (52,320)     (52,320)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) $ (5,116)         (5,116)    
Other comprehensive loss (26,445)             (26,445)
Share-based compensation on equity classified awards, net $ 3,374       3,374      
Purchase of treasury stock (in shares) (1,700)     (1,690)        
Purchase of treasury stock $ (34,193)     $ (34,193)        
Retirement of treasury stock (in shares)     (54,010) 54,010        
Retirement of treasury stock 0   $ (540) $ 553,973 (553,433)      
Issuance of common stock (in shares)     8,000          
Issuance of common stock 69,571   $ 80   69,491      
Issuance of common stock for share-based compensation (in shares)     447          
Issuance of common stock for share-based compensation 0   $ 5   (5)      
Exercise of common stock options (in shares)     110          
Exercise of common stock options $ 427   $ 1   426      
Balance as of end of period (in shares) at Dec. 30, 2020 63,962   63,962          
Balance as of end of period at Dec. 30, 2020 $ (130,446)   $ 640 $ 0 $ 123,833 $ (194,514)   $ (60,405)
Balance as of end of period, treasury stock (in shares) at Dec. 30, 2020 0     0